Cécile Dorange

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2010, Circulation.

A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2010, JACC. Cardiovascular interventions.

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W Serruys, Yoshinobu Onuma, Evelyn Regar, 2009, The Lancet.

Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.

Bernard Chevalier, Patrick W Serruys, Richard Rapoza, 2011, JACC. Cardiovascular interventions.

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2011, European heart journal.